Nei***rby

Chief Executive Officer

学歴

University of London

University of London (1983 - 1986)

  • Degree: PhD
  • Field of Study: Medicine
  • Description:

The School of Pharmacy, University of London (1979 - 1982)

  • Degree: B.Pharm.
  • Field of Study: Pharmacy
  • Description:

スキル:

Regulatory Affairs, Biotechnology, Drug Development, Clinical Development

職務経験:

Chief Executive Officer at Mulberry Biotherapeutics

  • Location: Boston, Massachusetts, United States
  • Duration: 2021-02 to Present
  • Description:

Consultant at Viridian Strategies

  • Location: Boston, Massachusetts, United States
  • Duration: 2020 to Present
  • Description:

CEO-in-Residence at BridgeBio

  • Location:
  • Duration: 2019 to 2020
  • Description:

Chief Executive Officer at Origin Biosciences

  • Location: Boston, Massachusetts, United States
  • Duration: 2018 to 2020
  • Description:

Chief Executive Officer at Phoenix Tissue Repair, Inc.

  • Location: Boston, Massachusetts, United States
  • Duration: 2017 to 2020
  • Description:
AI履歴書分析

候補者インテリジェンスレポート

米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。

キャリアの継続性とリスク評価

Employment GapLow

No evident gaps in employment; the candidate has held multiple overlapping leadership and consulting roles continuously from 2017 through the present.

Industry ConsistencyLow

All roles are within the biotech/biotherapeutics sector, with overlapping engagements that reinforce domain expertise and market relevance in the US.

Tenure StabilityMedium

Multiple concurrent CEO positions between 2017 and 2021 indicate portfolio leadership rather than single-role tenure; while this shows breadth, it reduces evident long-tenure at a single company.

Education-Career MatchMedium

Education lists University of London without a specified degree; while experience and leadership in biotech are strong, lack of degree specifics and US credential details introduce some uncertainty for certain US-based roles.

キャリア成長カーブ

Chief Executive Officer Entry
Phoenix Tissue Repair, Inc.
2017-2020
Chief Executive Officer Lateral
Origin Biosciences
2018-2020
Chief Executive Officer-in-Residence Lateral
BridgeBio
2019-2020
Consultant Lateral
Viridian Strategies
2020-Present
Chief Executive Officer ↑ 昇進
Mulberry Biotherapeutics
2021-Present
評価:The candidate demonstrates a clear upward trajectory in biotech leadership, with extensive CEO experience across multiple early-stage companies, complemented by strategic consulting. The overlap of roles suggests strong market demand for his leadership capabilities, making him well-positioned for senior C-suite roles or broader corporate leadership opportunities.

最適な役職(トップ5)

1

Chief Executive Officer (CEO) - Biotech Startup95% 適合

Extensive track record leading multiple biotech startups as CEO, with proven ability to drive fundraising, strategy, and growth.

2

Chief Development Officer (CDO) - Biotech90% 適合

Strong background in drug development, regulatory affairs, and clinical development; can lead end-to-end development strategy for programs.

3

Chief Operating Officer (COO) - Biotech85% 適合

Operational leadership across cross-functional teams in startups; complements prior CEO experience with scale-focused execution.

4

Head of Regulatory Affairs / VP Regulatory Affairs - Biotech82% 適合

Direct expertise in regulatory affairs and clinical development; valuable for companies seeking rapid regulatory progression.

5

Head of Corporate Strategy / VP Strategy - Biotech78% 適合

Consulting background and strategic leadership experience align with growth-stage biotech companies seeking strategy-driven governance.

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保